Associated Papers
Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients.
Makhtar SM et al.
Journal of Genetics, 2018
A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.
Grinfeld J et al.
British Journal of Haematology, 2013
Select a paper to view details